Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis

Circulation

Volumn 112, Issue 4, 2005, Pages 527-534

  Brueckmann, Martina ^a   Huhle, Guenter ^a   Lang, Siegfried ^a   Haase, Karl K ^a   Bertsch, Thomas ^b   Weiß, Christel ^a   Kaden, Jens J ^a   Putensen, Christian ^c   Borggrefe, Martin ^a   Hoffmann, Ursula ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Institute of Clinical Chemistry and Laboratory Medicine   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Coagulation; Infection; Natriuretic peptides; Sepsis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; DROTRECOGIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART DISEASE; HEART INJURY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; RISK ASSESSMENT; SEPSIS;

ADULT; AGED; APACHE; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROTEIN C; RECOMBINANT PROTEINS; SEPSIS; TROPONIN I; VENTRICULAR FUNCTION, LEFT;

EID: 23044465859     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.472050     Document Type: Article

References (38)

1. Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med. 2001;39:571-588.
2. Clerico A. Pathophysiological and clinical relevance of circulating levels of cardiac natriuretic hormones: are they merely markers of cardiac disease? Clin Chem Lab Med. 2002;40:752-760.
3. Hall C, Rouleau JL, Moyè L, de Champlain J, Bichet D, Klein M, Sussex B, Packer M, Rouleau J, Arnold MO, Lamas GA, Sestier F, Gottlieb S, Wun CC, Pfeffer MA. N-terminal proatrial natriuretic factor: an independent predictor of long-term prognosis after myocardial infarction. Circulation. 1994;89:1934-1942.
4. Gottlieb S, Kukin ML, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol. 1989;13:153-159.
5. Mitaka C, Nagura T, Sakanishi N, Tsunoda Y, Toyooka H. Plasma α-atrial natriuretic peptide concentrations in acute respiratory failure associated with sepsis: preliminary study. Crit Care Med. 1990;18: 1201-1203.
6. Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K, Suga S, Shirakami G, Jougasaki M, Imura H. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med. 1990;313:757-758.
7. Witthaut R, Busch C, Fraunberger P, Walli A, Seidel D, Pilz G, Stuttmann R, Speichermann N, Verner L, Werdan K. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med. 2003;29:1696-1702.
8. 126 is the storage form of rat atrial natriuretic peptide. Biochem J. 1987;241: 265-272.
9. Sundsfjord JA; Thibault G, Larochelle P, Cantin M. Identification and plasma concentration of the N-terminal fragment of pro-atrial natriuretic factor in man. J Clin Endocrinol Metab. 1988;66:605-610.
10. Price S, Anning SB, Mitchell JA, Evans TW. Myocardial dysfunction in sepsis: mechanisms and therapeutic implications. Eur Heart J. 1999;20: 715-724.
11. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ, for the PROWESS study group. Efficacy and safety of recombinant activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
12. Vincent JL, Light B, Wright T, Wong K, Johnson G, Bernard G, for the ENHANCE investigators. Global ENHANCE results indicate organ function improvement with drotrecogin alfa (activated) in severe sepsis patients. Chest. 2003;124(suppl):103S. Abstract.
13. Vincent JL; Angus DC; Artigas A, Kalil A, Basson BR, Jamal HH, Johnson G, Bernard GR, for the PROWESS Study Group. Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med. 2003;31:834-840.
14. Turner A, Tsamitros M, Bellomo R. Myocardial cell injury in septic shock. Crit Care Med. 1999;27:1775-1780.
15. Ammann P, Fehr T, Minder EI, Günter C, Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med. 2001;27:965-969.
16. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RMH, Sibbald WJ, for the ACCP/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644-1655.
17. Knaus WA, Draper EA, Wagner D, Zimmermann JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13: 818-829.
18. Baim DS, Grossmann W. Cardiac Catheterization, Angiography, and Intervention. 5th ed. Baltimore, Md: Williams & Wilkins; 1996.
19. Pilz G, Appel R, McGinn P. Calculation of the left ventricular stroke work index. Crit Care Med. 1993;21:1248-1249.
20. Slotwiner DJ, Devereux RB, Schwartz JE, Pickering TG, de Simone G, Ganau A, Saba PS, Roman MJ. Relation of age to left ventricular function in clinically normal adults. Am J Cardiol. 1998;82:621-626.
21. Parillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med. 1993;328:1471-1477.
22. Wiggers CJ. Myocardial depression in shock: a survey of cardiodynamic studies. Am Heart J. 1947;33:633-650.
23. Kumar A, Thota V, Dee L, Olson J, Uretz E, Parillo JE. Tumor necrosis factor alpha and interleukin 1 beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med. 1996;183:949-958.
24. Parker MM, Shelhamer JH, Natanson C, Ailing DW, Parillo J. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med. 1987;15:923-929.
25. Hartemink KJ, Groeneveld ABJ, de Groot MCM, Strack van Schijndel RJM, van Kamp G, Thijs LG. α-Atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock. Crit Care Med. 2001;29: 80-87.
26. Nugent AM, Onuoha GN, McEneaney DJ, Steele IC, Hunter SJ, Prasanna K. Campbell NP, Shaw C, Buchanan KD, Nicholls DP. Variable patterns of atrial natriuretic peptide secretion in man. Eur J Clin Invest. 1994;24: 267-274.
27. 2-terminal fragment of pro-atrial natriuretic factor in the circulation: identification, radioimmunoassay and half-life. Peptides. 1988;9:47-53.
28. Hammerer-Lercher A, Puschendorf B, Mair J. Cardiac natriuretic peptides: new laboratory parameters in heart failure patients. Clin Lab. 2001;47:265-277.
29. Mazul-Sunko B, Zarkovic N, Vrkic N, Klinger R, Peric M, Bekavac-Beslin M, Novkoski M, Krizmanic A, Gvozdenovic A, Topic E Pro-atrial natriuretic peptide hormone from right atria is correlated with cardiac depression in septic patients. J Endocrinol Invest. 2001;24:RC22-RC24.
30. Ver Elst KM, Spapen HD, Nguyen DN, Garbar C, Huyghens LP, Gorus FK. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem. 2000;46:650-657.
31. Ammann P, Maggiorini M, Bertel O, Haenseler E, Joller-Jemelka HI, Oechslin E, Minder EI, Rickli H, Fehr T. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol. 2003;41:2004-2009.
32. Wu AHB. Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression? Intensive Care Med. 2001;27:959-961.
33. Arlati S, Brenna S, Prencipe L, Marochi A, Casella GP, Lanzani M, Gandini C. Myocardial necrosis in ICU patients with acute non-cardiac disease: a prospective study. Intensive Care Med. 2000;26:31-37.
34. Beranek JT. Cardiomyocyte apoptosis contributes to the pathology of the septic shock heart. Intensive Care Med. 2002;28:218.
35. Arakawa N, Nakamura A, Aoki H, Hiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol. 1996;27:1656-1661.
36. McLean AS, Huang SJ, Nalos M, Tang B, Stewart DE. The confounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B-type natriuretic peptide concentrations in critically ill patients. Crit Care Med. 2001;31:2611-2618.
37. Hermann Z, Uhl W, Steinberg HW, Dworschack R. The influence of renal function on NT-proBNP levels in various disease groups. Clin Lab. 2003;49:649-656.
38. Hoffmann JN, Vollmar B, Laschke MW, Inthorn D, Fertmann J, Schildberg FW, Menger MD. Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia. Crit Care Med. 2004;32:1011-1017.